Pharmaceutical Technology on MSN11h
FDA approves Lilly’s obesity med Zepbound to treat obstructive sleep apnoeaLilly’s Zepbound has become the first prescription medicine approved to treat adults with moderate to severe obstructive sleep apnoea (OSA) and obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback